International Pancreas Transplant Registry. Pancreas Transplants Pancreas Transplants 12/16/1966 – 12/31/2009 nUSA: n = 23,850 nNon USn = 11,365 1/10.

Slides:

Advertisements

Similar presentations

HEART TRANSPLANTATION

Advertisements

Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp,

HEART TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:

HEART TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:

J Heart Lung Transplant 2009;28: HEART TRANSPLANTATION Pediatric Recipients ISHLT 2009.

HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):

HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:

HEART TRANSPLANTATION Pediatric Recipients ISHLT 2008 J Heart Lung Transplant 2008;27:

Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University

PRA = 36% (21/58) Anti-A11 and B44.

Complement in Heart Allograft Biopsies E. Rene Rodriguez W. M. Baldwin, III.

Scandiatransplant Waiting List Denmark James Heaf.

What makes a pancreas allograft marginal? Peter J Friend University of Oxford.

HEART TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):

RENAL TRANSPLANTATION INTO HIGH RISK, HIGHLY SENSITIZED RECIPIENTS: A SINGLE CENTER EXPERIENCE Randy Hennigar PhD, MD Director, Nephropathology and Electron.

Let’s get started. BETA CELL REPLACEMENT (PANCREAS AND ISLET TRANSPLANTATION) FOR THE TREATMENT OF DIABETES MELLITUS.

BACKGROUND ON PANCREAS HISTOLOGICAL FINDINGS: University of Maryland experience John C. Papadimitriou, M.D.,Ph.D. Professor of Pathology.

The Deceased Donor Kidney Allocation System

Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.

HEART TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant Oct; 31(10):

The Role of Pancreas Transplantation in the Long Term Management of Diabetes Christopher Johnson MD Professor of Surgery Division of Transplant Surgery.

© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,

Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.

© ANZOD Registry Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the.

Patient Survival USA Primary DD Pancreas Transplants 1/1/2004 – 12/31/2008 Categoryn 1Yr Surv. PTA % PAK1, % SPK4, % 2/09.

Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.

David C. Mulligan, MD, FACS

CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,

Tolerance Induction after Kidney Transplantation Stephan Busque MD M Sc FRCSC Director, Adult Kidney and Pancreas Transplantation Program Stanford University.

HEART TRANSPLANTATION Pediatric Recipients JHLT Oct; 32(10):

Israel David and Michal Moatty-Assa The Search for Compatible Organs – A Handy Aid.

Kidney Kidney-Pancreas Pancreas Liver Heart Lung Intestine ,953 1, ,306 3,069 2, ,318 24,175 8, ,642.

When Using SRTR Slides. SRTR Slide Use Guidelines.

The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.

UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:

© ANZDATA Registry TRANSPLANT WAITING LIST CHAPTER 7.

TRANSPLANTATION CHAPTER 8 ANZDATA Registry Annual Report 2013.

Transplantation in the Diabetic Patient The Status of Pancreas transplantation A. Osama Gaber Professor of Surgery Director of the Transplant Institute,

M ORNING R EPORT February 17, R ENAL T RANSPLANTS Most frequent transplant 45% of all pediatric transplants 7% of renal transplants ≤ 17y 3 year.

INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.

UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.

Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric.

Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.

HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):

Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.

Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths.

HEART-LUNG TRANSPLANTATION Pediatric Recipients 2015 JHLT Oct; 34(10):

United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.

THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY

Graft Dysfunction after Heart Transplantation

Table S1: Antibodies Used for Flow Cytometric Analysis

Australian Kidney Transplant Waiting List Stock and Flow

ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.

Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation Johann Pratschke, Duska Dragun, Ingeborg A. Hauser,

Summary of the 2013 ERA-EDTA Registry Annual Report

Number of transplants, by donor type figure 8.1

Volume 2: End-Stage Renal Disease Chapter 6: Transplantation

Renal transplants in Scandiatransplant

Volume 2: End-Stage Renal Disease Chapter 6: Transplantation

التعلم بالإكتشاف المراجع:

ANZDATA Registry Annual Report 2013

THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Heart Retransplantation: A 23-Year Single-Center Clinical Experience

Number of Donors in Australia

Number of Donors in Australia

Pancreas transplantation is performed at transplant centers within 56 of the 58 federally designated donor service areas (DSAs). Pancreas transplantation.

Presentation transcript:

International Pancreas Transplant Registry

Pancreas Transplants Pancreas Transplants 12/16/1966 – 12/31/2009 nUSA: n = 23,850 nNon USn = 11,365 1/10

US Pancreas Transplants USA Pancreas Transplants 12/16/1966 – 12/31/2010 USA: n = 25,031 1/11

Number of Tx Centers and Number of Txs 01/11 Transplants USA Pancreas Transplants 1/1/1988 – 12/31/2010

Pancreas Transplant Categories USA SPK, PAK and PTA Transplants 1/1/1988 – 12/31/ /11

Pancreas Retransplants USA Pancreas Transplants 1/1/1988 – 12/31/2010 1/11 #

USA Primary Pancreas Transplants 1/1/1988 – 12/31/2010 Type of Primary and Retransplant

Recipient Age USA Primary Pancreas Transplants 1/1/1988 – 12/31/2010 PAK PTA SPK

Duration of Diabetes USA Primary DD Pancreas Transplants 1/1/1996 –12/31/2010 PAK PTA SPK

Age at Tx by Diabetes Type USA Primary DD Pancreas Transplants 1/1/2006 –12/31/2010

Diabetes Type and Duration USA Primary DD Pancreas Transplants 1/1/2000 –12/31/2008

Recipient Gender USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010 1/11 % Male

Patients with Type 2 Diabetes USA Primary DD Pancreas Transplants 1/1/1994 – 12/31/2010 2/11

AfricanAmerican Recipients USA Primary DD Pancreas Transplants 1/1/1994 – 12/31/2010 2/11

Duct Management Technique USA DD Primary Pancreas Transplants 1/1/1988 –12/31/2010 2/11

Portal Drainage in ED Txs USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2010 2/11

Use of a Roux-Loop in ED Txs USA Primary DD Pancreas Transplants, 1/1/1996 – 12/31/2010 2/11

HLA A,B,DR Mismatching USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010 3/11 % of 5 or 6 HLA Mismatch

Anti-T-Cell Induction USA DD Primary Pancreas Transplants 1/1/1988 – 12/31/2010 2/11

Class I PRA levels > 20% USA DD Primary Pancreas Transplants 7/1/2004 – 12/31/2010 2/11

Class II PRA levels > 20% USA DD Primary Pancreas Transplants 7/1/2004 – 12/31/2010 2/11

SPK Induction Antibody Therapy USA DD Primary Pancreas Transplants 1/1/2000 – 12/31/2010 3/11

PAK Induction Antibody Therapy USA DD Primary Pancreas Transplants 1/1/2000 – 12/31/2010 3/11

PTA Induction Antibody Therapy USA DD Primary Pancreas Transplants 1/1/2000 – 12/31/2010 3/11

Antibody Therapy USA Primary DD Pancreas Transplants 1/1/2006 – 12/31/2010 No ABs Depl. AB NonDepl. AB Both ABs 3/11

Overall Initial Steroid Avoidance USA Primary DD Pancreas Transplants 1/1/2000 – 12/31/2010 3/11

Major Immunosuppressive Protocols USA Primary DD Pancreas Transplants 1/1/2006 – 12/31/2010 3/11